"Prairie Lakes Healthcare System (PLHS) is licensed to operate 81 acute care hospital beds including Labor and Delivery, Telemetry, Critical Care, and general hospital. Hospital services also include a 24-hour emergency department, surgery capabilities, Interventional Cardiology, and services providing diagnostics and imaging services. PLHS also operates Prairie Lakes Cancer Center, Prairie Lakes Mallard Pointe Surgical Center, dialysis units in Sisseton, SD, Watertown, SD and Ortonville, MN, rehabilitation services, and specialty services. Specialty services are a focus of PLHS to bring needed care to the region. These specialties include Cardiology, Dermatology, Ear, Nose & Throat, General Surgery, Hospice, Home Care, Nephrology, Pulmon..."

During the past decade, Prairie Lakes Health Care System, Inc. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prairie Lakes Health Care System, Inc." #1 sponsor was "Gilead Sciences" with 3 trials, followed by "BeiGene" with 2 trials sponsored, "Geron Corporation" with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prairie Lakes Health Care System, Inc." #1 collaborator was "ICON Clinical Research" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Prairie Lakes Health Care System, Inc." are "Chronic Lymphocytic Leukemia" (2 trials), "Follicular Lymphoma" (2 trials), "Advanced Multiple Myeloma" (1 trials), "Chronic Myeloid Leukemia" (1 trials) and "Diffuse Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Prairie Lakes Health Care System, Inc." in a lesser frequency.

Most popular intervention types in "Prairie Lakes Health Care System, Inc." are "Drug" (15 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Imetelstat" (2 trials), "Rituximab" (2 trials), "rituximab" (2 trials) and "5-fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prairie Lakes Health Care System, Inc." are 16 trials for "All" genders.

Currently, there are NaN active trials in "Prairie Lakes Health Care System, Inc.". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Prairie Lakes Health Care System, Inc., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Prairie Lakes Health Care System, Inc., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Prairie Lakes Health Care System, Inc. has several departments that took part in Clinical trials: "Prairie Lakes Cancer Center" - 3 trials